Clinical Trials Browser

INDUSTRY × Epstein-Barr Virus Infections × Lymphoid × Clear all

Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT04554914 2026-02-20

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Phase 2 Recruiting

190 enrolled

LymphoidSarcoma

Immunologic Deficiency Syndromes, Leiomyosarcoma, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT06761677 2026-02-05

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Phase 1/2 Suspended

43 enrolled

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Epstein-Barr Virus Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02822495 2023-06-15

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

No longer available

Head & NeckLymphoidSarcoma

Nasopharyngeal Carcinoma, Primary Immunodeficiency Diseases, Arthritis, Rheumatoid, Infections, Leiomyosarcoma, Lymphoma, Lymphoproliferative Disorders, Inflammatory Bowel Diseases, Lymphoma, AIDS-Related, Epstein-Barr Virus Infections

NCT02763254 2019-03-26

CIVIC

Phase 2 Terminated

1 enrolled 9 charts

Lymphoid

Hodgkin Disease, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

NCT01948180 2019-03-13

CITADEL

Phase 2 Terminated

15 enrolled

Lymphoid

Epstein-Barr Virus Infections, Lymphoma, Extranodal NK-T-Cell

NCT02229981 2017-12-07

ABC-102

Phase 1/2 Withdrawn